Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review

  • ID: 4225268
  • SWOT Analysis
  • 48 pages
  • GlobalData
  • Celsion Corporation
1 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Genentech Inc
  • Merck & Co Inc
  • Tesaro Inc
  • MORE
Celsion Corp (CLSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business Description - A detailed description of the company’s operations and business divisions.
  • Corporate Strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company History - Progression of key events associated with the company.
  • Major Products and Services - A list of major products, services and brands of the company.
  • Key Competitors - A list of key competitors to the company.
  • Key Employees - A list of the key executives of the company.
  • Executive Biographies - A brief summary of the executives’ employment history.
  • Key Operational Heads - A list of personnel heading key departments/functions.
  • Important Locations and Subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key Manufacturing Facilities - A list of key manufacturing facilities of the company.
  • Detailed Financial Ratios for the Past Five Years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim Ratios for the Last Five Interim Periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (LTSL), TheraPlas and TheraSilence provide the foundation for a wide range of therapeutics for common and difficult-to-treat forms of cancers. Its lead product candidate ThermoDox is a proprietary dosage form of doxorubicin based LTSL technology in a Phase III clinical trial for the treatment of non-resectable hepatocellular carcinoma (HCC) and a Phase II clinical trial for recurrent chest wall (RCW) breast cancer. It is also developing a comprehensive pipeline of targeted therapeutic agents. Celsion is headquartered in Lawrenceville, New Jersey, the US.

Celsion Corp Key Recent Developments

Mar 16,2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update
Nov 10,2016: Celsion Reports Third Quarter 2016 Financial Results
Aug 15,2016: Celsion Reports Second Quarter 2016 Financial Results and Provides Business Update
May 16,2016: Celsion Reports First Quarter 2016 Financial Results and Provides Business Update
Mar 30,2016: Celsion Reports Year End 2015 Financial Results and Provides Business Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amgen Inc
  • Genentech Inc
  • Merck & Co Inc
  • Tesaro Inc
  • MORE
Section 1 - About the Company
Celsion Corp - Key Facts
Celsion Corp - Key Employees
Celsion Corp - Key Employee Biographies
Celsion Corp - Major Products and Services
Celsion Corp - Pharmaceutical Pipeline Products Data
Celsion Corp, Pipeline Products by Therapy Area
Celsion Corp, Pipeline Products by Development Phase
Celsion Corp - History
Celsion Corp - Company Statement
Celsion Corp - Locations And Subsidiaries
Head Office

Section 2 - Company Analysis
Celsion Corp - Business Description
Celsion Corp - Corporate Strategy
Celsion Corp - SWOT Analysis
SWOT Analysis - Overview
Celsion Corp - Strengths
Celsion Corp - Weaknesses
Celsion Corp - Opportunities
Celsion Corp - Threats
Celsion Corp - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Celsion Corp, Recent Deals Summary

Section 5 - Company’s Recent Developments
Mar 16, 2017: Celsion Reports Year End 2016 Financial Results and Provides Business Update
Nov 10, 2016: Celsion Reports Third Quarter 2016 Financial Results
Aug 15, 2016: Celsion Reports Second Quarter 2016 Financial Results and Provides Business Update
May 16, 2016: Celsion Reports First Quarter 2016 Financial Results and Provides Business Update
Mar 30, 2016: Celsion Reports Year End 2015 Financial Results and Provides Business Update

Section 6 - Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables:
Celsion Corp, Key Facts
Celsion Corp, Key Employees
Celsion Corp, Key Employee Biographies
Celsion Corp, Major Products and Services
Celsion Corp, Number of Pipeline Products by Therapy Area
Celsion Corp, Number of Pipeline Products by Development Stage
Celsion Corp, History
Celsion Corp, Key Competitors
Celsion Corp, Ratios based on current share price
Celsion Corp, Annual Ratios
Celsion Corp, Annual Ratios (Cont...1)
Celsion Corp, Interim Ratios
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Celsion Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures:
Celsion Corp, Pipeline Products by Therapy Area
Celsion Corp, Pipeline Products by Development Phase
Celsion Corp, Performance Chart (2012 - 2016)
Celsion Corp, Ratio Charts
Celsion Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Celsion Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Tesaro Inc
  • Merck & Co Inc
  • Genentech Inc
  • Bristol-Myers Squibb Company
  • Amgen Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll